Developer of a biotechnology platform designed to offer technologies for novel gene therapies.
Company Profile
Founded
2018
HQ
Watertown, MA
Employees
92
Total Raised
$111M
Last Round
Series A — $100M (May 2021)
IPO Status
private
Fundraising Status
Series A · $100M · 5y 3mo ago
privateTotal raised $111M
Secondary Market
Implied price / share
$25.37
Last round price / share
$44.66
vs last round
-43.2%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series A
$100M
May 2021
—
$500M
Biotechnology
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.